Skip to content
Independent analysis of NHS open data
PharmaInsight

Cladribine (Immunomodulating)

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802040AY
Data updated February 2023 Download CSV

Cladribine (Immunomodulating) was dispensed in England in February 2023, with 1 items, little changed on a year earlier.

1items 0%

Dispensed in February 2023

0items

Rolling 12 months

£2,047

Net ingredient cost · February 2023

Figure 1. Cladribine (Immunomodulating): national items dispensed by month

0 0.5 1 Dec 2021 Mar 2022 May 2022 Aug 2022 Oct 2022 Feb 2023 1 Dec 2021: 1 Feb 2022: 1 Mar 2022: 1 Apr 2022: 1 May 2022: 1 Jun 2022: 1 Aug 2022: 1 Sep 2022: 1 Oct 2022: 1 Nov 2022: 1 Dec 2022: 1 Feb 2023: 1

Source: NHSBSA Prescription Cost Analysis, to February 2023

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs affecting the immune response
  • Presentations 1 shown
  • Average cost / item £2,047.24
  • Year on year Little changed on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, February 2023

The individual products dispensed under Cladribine (Immunomodulating) this month.

Presentations of Cladribine (Immunomodulating), February 2023
Presentation BNF code Items Net ingredient cost
Mavenclad 10mg tablets 0802040AYBBAAAA 1 £2,047

Source: NHSBSA Prescription Cost Analysis · to February 2023 OGL v3.0

Where Cladribine (Immunomodulating) is dispensed

The regions and dispensing practices with the highest Cladribine (Immunomodulating) volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Cladribine (Immunomodulating) with

Other medicines in the same BNF section, by prescribing volume.